Morphothiadine Mesylate

甲磺酸莫非赛定

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameMorphothiadine Mesylate
Drug Alias Name莫非赛定MorphothiadinMorphothiadine mesilate东安帝GLS4JHS +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein inhibitors
TargetsCapsid protein
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSouth China Center For Innovative PharmaceuticalsGuangdong Dongyangguang Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSunshine Lake Pharma Co LtdGuangdong Dongyangguang Pharmaceutical Co LtdSouth China Center For Innovative Pharmaceuticals
Inactive CompaniesRuyuan Yao Autonomous County Dongyang Sunshine Enterprise Management Co Ltd
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A